ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Pepperstone

Trade Now

Pepperstone
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
S&P ASX 200
7,569.90
0.00%
S&P ASX All Technology
2,968.80
0.00%
Brent Oil
83.45
-2.85%
US Dollar vs AUD
1.53294
-0.73%
Bitcoin
57,214.86
-5.60%
Registration Strip Icon for pro Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. Renalytix PLC (RNLX)

  7. Renalytix PLC (RNLX) News

RNLX Renalytix PLC

0.79
0.0971 (14.01%)
After Hours
Last Updated: 06:42:11
Delayed by 15 minutes
Share Name Share Symbol Market Stock Type
Renalytix PLC RNLX NASDAQ Depository Receipt
  Price Change Price Change % Share Price Last Trade
Upgrade Icon
0.0971 14.01% 0.79 06:42:11
Open Price Low Price High Price Close Price Previous Close
0.69 0.69 0.80 0.79 0.6929
more quote information »

Recent News

Date Time Source Heading
08/4/202421:00GLOBERenalytix Announces Financing with Expected Size of up to $4..
14/3/202422:00GLOBEKidneyIntelX™ included in Final KDIGO 2024 Clinical..
15/2/202423:00GLOBERenalytix Reports Financial Results for Second Quarter of..
15/2/202423:00EDGAR2Form 8-K - Current report
15/2/202408:31EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
10/2/202401:00GLOBERenalytix to Participate in the BTIG MedTech, Digital..
17/1/202423:15EDGAR2Form 8-K - Current report
10/1/202423:15EDGAR2Form 8-K - Current report
10/1/202423:00GLOBENew published data demonstrates KidneyIntelX™ has broad..
30/12/202308:02EDGAR2Form 8-K - Current report
18/11/202308:01EDGAR2Form ARS - Annual Report to Security Holders
14/11/202323:00GLOBERenalytix Reports Financial Results for First Quarter of..
07/11/202323:00GLOBERenalytix to Report Financial Results for First Quarter..
04/11/202307:04EDGAR2Form PRE 14A - Other preliminary proxy statements
24/10/202323:00EDGAR2Form 8-K - Current report
06/10/202322:00GLOBEUS Patent Office Allows Patent Claims for Intellectual..
28/9/202321:00GLOBERenalytix Reports Full Year Fiscal 2023 Results
25/9/202321:00GLOBERenalytix to Report Financial Results for Fourth Quarter and..
09/9/202306:04EDGAR2Form 8-K - Current report
07/9/202321:00GLOBERenalytix Appoints Senior Executive Howard Doran as Chief..
03/8/202321:00GLOBERenalytix Clinical Advisory Board Formed to Support..
21/7/202321:00GLOBERenalytix Announces Middle East Distribution Agreement with..
07/7/202321:00GLOBELate-Breaking KidneyIntelX Evidence Released at 83rd..
03/7/202321:00GLOBERenalytix Appoints Financial Executive Catherine Coste to..
30/6/202308:58DJNRenalytix Gets FDA De Novo Marketing Authorization for..
30/6/202308:01GLOBEFDA Grants De Novo Marketing Authorization for..
15/6/202321:00GLOBEKidneyIntelX™ Clinical Decision Impact / Validation and..
09/6/202321:00GLOBERenalytix Reports Financial Results for Third Quarter of..
05/6/202321:00GLOBERenalytix to Report Third Quarter Fiscal Year 2023 Financial..
25/5/202321:00GLOBERenalytix selects EVERSANA® to expand commercialization of..

Your Recent History

NASDAQ
RNLX
Renalytix
Delayed Upgrade Clock
ADVFN Logo

Australia
Company
Business
Popular
Get The App

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved